Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1

By sjmartinez • October 4, 2022

Youn JY, Wang J, Li Q, Huang K, Cai H. Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1. Front Cardiovasc Med. 2022 Sep 15;9:957340. doi: 10.3389/fcvm.2022.957340. PMID: 36187008; PMCID: PMC9520320.

Tags: acute respiratory distress syndrome (ARDS), Cardiology/Epi, covid-19, endothelial dysfunction, NADPH oxidase isoform 2 (NOX2), Publications, SARS-CoV-2

Program Directors Survey on Competency Assessment in Cardiology Fellowship

Cullen MW, Yang EH, Soukoulis V, Keating FK, Abudayyeh I, Kondapaneni M, Polk DM, Theriot P, Damp JB, Weissman G. Program Directors Survey on Competency[...]

Prevalence of Hypertension in Young Athletes: A Community-Based Screening Analysis

Malik A, Virdi J, Le T, Sanavi A, Nandakumar S, Ziaeian B, Mefferd K, Gladkikh S, Hsu JJ. Prevalence of Hypertension in Young Athletes: A[...]

Deep Learning-Based Denoising for High-Resolution Carotid Vessel Wall MRI Using Standard Neurovascular Coils

Zeng L, Hsu YC, Wang L, Lu M, Keushkerian M, Nguyen KL, Johnson KJ, Altbach MI, Morris HD, DeMarco JK, Deshpande V, Mitsouras D, Saloner[...]